These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1904850

  • 1. The successful treatment of Branhamella catarrhalis bronchopulmonary infections in adults with amoxycillin.
    Seto WH, Yuen KY.
    J Antimicrob Chemother; 1991 Jan; 27(1):146-7. PubMed ID: 1904850
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis.
    Fernández-Roblas R, Jiménez Arriero M, Rodriguez-Tudela JL, Soriano F.
    J Antimicrob Chemother; 1988 Dec; 22(6):867-72. PubMed ID: 3149634
    [Abstract] [Full Text] [Related]

  • 5. The influence of culture medium on the comparative in-vitro activity of amoxycillin and amoxycillin/clavulanic acid against Branhamella catarrhalis.
    Soriano F, Jiménez-Arriero M, Fernández-Roblas R.
    J Antimicrob Chemother; 1987 Aug; 20(2):285-6. PubMed ID: 3117763
    [No Abstract] [Full Text] [Related]

  • 6. Minimal criteria for identification of Moraxella (Branhamella) catarrhalis.
    Jönsson I, Eriksson B, Krook A.
    APMIS; 1990 Oct; 98(10):954-6. PubMed ID: 2123112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Bacteremic pneumonia caused by Branhamella catarrhalis in an immunocompromised patient].
    Mendarte U, Collazos J, Egurbide MV, de Miguel J.
    Med Clin (Barc); 1991 Apr 13; 96(14):559. PubMed ID: 1904967
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G, Legnani D, De Bartolo A, Pagani N, Lusco G.
    J Chemother; 1995 Nov 13; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract] [Full Text] [Related]

  • 20. [Bronchopulmonary infection due to Branhamella catarrhalis in patients with obstructive lung disease].
    Wu LB.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec 13; 13(6):328-30, 378. PubMed ID: 2128216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.